References
  • 1 Agrawal, P.P., Singhal, S.S., Neema, J.P., et al. (2005) The role of interstitial brachytherapy using template in locally advanced gynecological malignancies. Gynecologic Oncology, 99(1), 169–175. Cross Ref link Pubmed link | Cite this reference
  • 2 Anglesio, S., Calamia, E., Fiandra, C., et al. (2005) Prostate brachytherapy with iodine‐125 seeds: radiation protection issues. Tumori, 91(4), 335–338. Pubmed link | Cite this reference
  • 3 Beetz, R. (2003) Mild dehydration: a risk factor for urinary tract infection? European Journal of Clinical Nutrition, 57(Suppl 2), S52–S58. Cross Ref link Pubmed link | Cite this reference
  • 4 Bergmark, K., Avall‐Lundqvist, E., Dickman, P.W., Henningsohn, L. & Steineck, G. (1999) Vaginal changes and sexuality in women with a history of cervical cancer. New England Journal of Medicine, 340(18), 1383–1389. Cross Ref link Pubmed link | Cite this reference
  • 5 Blake, P.R., Lambert, H.E. & Crawford, R. (1998) Gynaecological Oncology: A Guide to Clinical Management. Oxford: Oxford University Press. | Cite this reference
  • 6 Blank, L.E., Gonzalez Gonzalez, D., de Reijke, T., et al. (2000) Brachytherapy with transperineal [125]‐iodine seeds for localized prostate cancer. Radiotherapy and Oncology, 57(3), 307–313. Cross Ref link Pubmed link | Cite this reference
  • 7 Bomford, C.K (2002a) Radiation protection. In: Bomford, C.K. & Kunkler, I.K. (eds) Walters and Miller Textbook of Radiotherapy, 6th edn. Edinburgh: Churchill Livingstone, pp. 69–88. | Cite this reference
  • 8 Bomford, C.K. (2002b) Brachytherapy. In: Bomford, C.K. & Kunkler, I.K. (eds) Walters and Miller Textbook of Radiotherapy, 6th edn. Edinburgh: Churchill Livingstone, pp. 225–244. | Cite this reference
  • 9 Brophy, P., Schmus, C. & Balistreri, L. (2004) Meeting the nursing challenge in treating children with 131 I‐mIBG. Journal of Paediatric Oncology Nursing, 21(1), 9–15. Cross Ref link | Cite this reference
  • 10 Budrukkar, A.N., Shrivastava, S.K., Jalali, R., et al. (2001) Transperineal low‐dose rate iridium‐192 interstitial brachytherapy in cervical carcinoma stage IIB. Strahlentherapie und Onkologie, 177(10), 517–524. Cross Ref link Pubmed link | Cite this reference
  • 11 Chen, S.W., Liang, J.A., Yang, S.N., et al. (2004) Radiation injury to intestine following hysterectomy and adjuvant radiotherapy for cervical cancer. Gynecologic Oncology, 95(1), 208–214. Cross Ref link Pubmed link | Cite this reference
  • 12 Cormack, J., Towson, J.E.C. & Flower, M.A. (1998) Radiation protection and dosimetry in clinical practice. In: Murray, I.P.C. & Ell, P.J. (eds) Nuclear Medicine in Clinical Diagnosis and Treatment, 2nd edn. Edinburgh: Churchill Livingstone, pp. 1651–1677. | Cite this reference
  • 13 Darby, S. (1999) Radiation risks. BMJ, 319 (7216), 1019–1020. Cross Ref link Pubmed link | Cite this reference
  • 14 DH (2000) Ionising Radiation (Medical Exposure) Regulations No. 1059. London: HMSO. | Cite this reference
  • 15 DH (2016) Regulatory controls for radiation protection in the UK. Available at: https://www.gov.uk/guidance/regulatory‐controls‐for‐radiation‐protection‐in‐the‐uk (Accessed: 1/5/2018)
  • 16 Dougherty, L. & Lister, S. (eds) (2011) The Royal Marsden Manual of Clinical Nursing Procedures: Professional Edition. 8th edn. Oxford: Wiley‐Blackwell. | Cite this reference
  • 17 Faithfull, S. & Wells, M. (2003) Supportive Care in Radiotherapy. Edinburgh: Churchill Livingstone. | Cite this reference
  • 18 Faithfull, S. & White, I. (2008) Delivering sensitive healthcare information challenging the taboo of women's sexual health after pelvic radiotherapy. Patient Education and Counseling, 71(2), 228–233. Cross Ref link Pubmed link | Cite this reference
  • 19 Farrell, E. (2002) Premature menopause. ‘I feel like an alien’. Australian Family Physician, 31(5), 419–421. Pubmed link | Cite this reference
  • 20 Fitch, M.I. & McGrath, P.N. (2003) The needs of family members of patients receiving radioactive iodine. Canadian Oncology Nursing Journal, 13(4), 220–231. Cross Ref link Pubmed link | Cite this reference
  • 21 Fung, A.Y. (2002) The Syed temporary interstitial iridium gynaecological implant: an inverse planning system. Physics in Medicine and Biology, 47(16), N203–N208. Cross Ref link Pubmed link | Cite this reference
  • 22 Gami, B., Harrington, K., Blake, P., et al. (2003) How patients manage gastrointestinal symptoms after pelvic radiotherapy. Alimentary Pharmacology and Therapeutics, 18(10), 987–994. Cross Ref link Pubmed link | Cite this reference
  • 23 Gosselin, T.K. & Waring, J.S. (2001) Nursing management of patients receiving brachytherapy for gynaecologic malignancies. Clinical Journal of Oncology Nursing, 5(2), 59–63. Pubmed link | Cite this reference
  • 24 Grabenbauer, G.G., Rodel, C., Brunner, T., et al. (2001) Interstitial brachytherapy with Ir‐192 low‐dose‐rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997. Strahlentherapie und Onkologie, 177(7), 338–344. Cross Ref link Pubmed link | Cite this reference
  • 25 Hart, S. (2006) Ionising radiation: promoting safety for patients, visitors and staff. Nursing Standard, 20(47), 47–57. Cross Ref link Pubmed link | Cite this reference
  • 26 Health Protection Agency (HPA) (2006) Administration of Radioactive Substances Advisory Committee, Guidance Notes. London: Health Protection Agency. | Cite this reference
  • 27 Health Protection Agency (HPA) (2010) www.hpa.org.uk/radiation.
  • 28 Hoskin, P. & Coyle, C. (2005) Radiotherapy in Practice: Brachytherapy. Oxford: Oxford University Press. | Cite this reference
  • 29 HSE (2003a) Five Steps to Risk Assessment. Norwich: Health and Safety Executive Books. | Cite this reference
  • 30 HSE (2003b) Safe Working and the Prevention of Infection in Clinical Laboratories and Similar Facilities. Norwich: Health and Safety Executive Books. | Cite this reference
  • 31 Institute of Physics and Engineering in Medicine/Royal College of Nursing (IPEM/RCN) (2002) Procedures involving radiation. In: Ionising Radiation Safety. A Handbook for Nurses. York: York Publishing, pp. 17–32. | Cite this reference
  • 32 International Commission on Radiological Protection (ICRP) (2004) Release of patients after therapy with unsealed radionuclide. Annals of the ICRP, 34(20), v–vi and 1–79. Cross Ref link Pubmed link | Cite this reference
  • 33 International Commission on Radiological Protection (ICRP) (2005) Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. ICRP Publication 98. Annals of the ICRP, 35(3), iii–vi and 3–50. Cross Ref link Pubmed link | Cite this reference
  • 34 Ionising Radiations Regulations (IRR) (1999) London: HMSO. | Cite this reference
  • 35 Ionising Radiation (Medical Exposure) Regulations (IRMER) (2000). Available at: https://www.gov.uk/government/publications/the‐ionising‐radiation‐medical‐exposure‐regulations‐2000 (Accessed: 3/4/2018)
  • 36 Jefferies, H., Hoy, S., McCahill R. & Crichton, A. (2007) The development of Best Practice guidelines for the use of vaginal dilators following pelvic radiotherapy. Nursing Times, 103(30), 28–29. | Cite this reference
  • 37 Jones, B., Pryce, P., Blake, P. & Dale, R. (1999) High dose brachytherapy practice for the treatment of gynaecological cancers in the UK. British Journal of Radiology, 72(856), 371–377. Cross Ref link Pubmed link | Cite this reference
  • 38 Karakoyun‐Celik, O., Norris, C. Jr., Tishler, R., et al. (2005) Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base. Head and Neck, 27(5), 353–361. Cross Ref link Pubmed link | Cite this reference
  • 39 Kucera, H., Mock, U., Knocke, T., et al. (2001) Radiotherapy alone for invasive vaginal cancer: outcome with intracavitary high dose rate brachytherapy versus conventional low dose rate brachytherapy. Acta Obstetrica et Gynecologica Scandinavica, 80(4), 355–360. Cross Ref link | Cite this reference
  • 40 Kuipers, T., Hoekstra, C., van't Riet, A., et al. (2001) HDR brachytherapy applied to cervical carcinoma with moderate lateral expansion: modified principles of treatment. Radiotherapy and Oncology, 58(1), 25–30. Cross Ref link Pubmed link | Cite this reference
  • 41 Lalos, A. (1997) The impact of diagnosis on cervical and endometrial cancer patients and their spouses. European Journal of Gynaecological Oncology, 18(6), 513–519. Pubmed link | Cite this reference
  • 42 Lalos, A., Jacobsson, L., Lalos, O. & Stendahl, U. (1995) Experiences of the male partner in cervical and endometrial cancer – a prospective interview study. Journal of Psychosomatic Obstetrics and Gynecology, 16(3), 153–165. Cross Ref link Pubmed link | Cite this reference
  • 43 Lancaster, L. (2004) Preventing vaginal stenosis after brachytherapy for gynaecological cancer: an overview of Australian practices. European Journal of Oncology Nursing, 8(1), 30–39. Cross Ref link Pubmed link | Cite this reference
  • 44 Lapeyre, M., Bollet, M., Racadot, S., et al. (2004) Postoperative brachytherapy alone and combined postoperative radiotherapy and brachytherapy boost for squamous cell carcinoma of the oral cavity, with positive or close margins. Head and Neck, 26(3), 216–223. Cross Ref link Pubmed link | Cite this reference
  • 45 Leborgne, F., Leborgne, J.H., Zubizarreta, E. & Mezzera, J. (2002) Cesium‐137 needle brachytherapy boosts after external beam irradiation for locally advanced carcinoma of the tongue and floor of the mouth. Brachytherapy, 1(3), 126–130. Cross Ref link Pubmed link | Cite this reference
  • 46 Leung, P.M. & Nikolic, M. (1998) Disposal of therapeutic 131‐I waste using a multiple holding tank system. Health Physics, 75(3), 315–321. Cross Ref link Pubmed link | Cite this reference
  • 47 Montgomery, C., Lydon, A. & Lloyd, K. (1999) Psychological distress among cancer patients and informed consent. Journal of Psychosomatic Research, 46(3), 241–245. Cross Ref link Pubmed link | Cite this reference
  • 48 Muscari Lin, E., Aikin, J.L. & Good, B.C. (1999) Premature menopause after cancer treatment. Cancer Practice, 7(3), 114–121. Cross Ref link Pubmed link | Cite this reference
  • 49 Nag, S., Yacoub, S., Copeland, L.J. & Fowler, J.M. (2002) Interstitial brachytherapy for salvage treatment of vaginal recurrences in previously unirradiated endometrial cancer patients. International Journal of Radiation Oncology, Biology, Physics, 54(4), 1153–1159. Cross Ref link Pubmed link | Cite this reference
  • 50 NICE (2005) Low dose rate brachytherapy for localised prostate cancer [IPG132]. London: National Institute for Health and Clinical Excellence. Available at: www.nice.org.uk/IPG132 (Accessed: 3/4/2018)
  • 51 NMC (2009) Record Keeping: Guidance for Nurses and Midwives. London: Nursing & Midwifery Council. | Cite this reference
  • 52 NMC (2010) Standards for Medicines Management. London: Nursing & Midwifery Council. | Cite this reference
  • 53 Nutting, C., Horlock, N., A'Hern, R., et al. (2006) Manually afterloaded 192Ir low‐dose rate brachytherapy after subtotal excision and flap reconstruction of recurrent cervical lymphadenopathy from head and neck cancer. Radiotherapy and Oncology, 80(1), 39–42. Cross Ref link Pubmed link | Cite this reference
  • 54 O'Dwyer, H.M., Lyon, S., Fotheringham, T. & Lee, M. (2003) Informed consent for interventional radiology procedures: a survey detailing current European practice. Cardiovascular and Interventional Radiology, 26(5), 428–433. Cross Ref link Pubmed link | Cite this reference
  • 55 Pearson, D., Rogers, A.T. & Moss, E. (2001) A generic approach to risk assessment for the Ionising Radiation Regulations 1999. British Journal of Radiology, 74(877), 62–68. Cross Ref link Pubmed link | Cite this reference
  • 56 Petereit, D.G., Sarkaria, J.N. & Chappell, R.J. (1998) Perioperative morbidity and mortality of high‐dose‐rate gynecologic brachytherapy. International Journal of Radiation Oncology, Biology, Physics, 42(5), 1025–1031. Cross Ref link Pubmed link | Cite this reference
  • 57 Picano, E. (2004) Informed consent and communication of risk from radiological and nuclear medicine examination: how to escape from a communication inferno. BMJ, 329(7470), 849–851. Cross Ref link Pubmed link | Cite this reference
  • 58 Public Health England (PHE) (2014) Guidance Radiation: products and services. Available at: https://www.gov.uk/guidance/radiation‐products‐and‐services. (Accessed 18/6/18) | Cite this reference
  • 59 RIDDOR (1995) The Reporting of Injuries, Diseases and Dangerous Occurrences Regulations. London: HMSO. | Cite this reference
  • 60 Rossoff, L.J., Lam, S., Hilton, E., Borenstein, M. & Isenberg, H.D. (1993) Is the use of boxed gloves in an intensive care unit safe? American Journal of Medicine, 94(6), 602–607. Cross Ref link Pubmed link | Cite this reference
  • 61 Skalla, K.A., Bakitas, M., Furstenberg, C.T., Ahles, T. & Henderson, J.V. (2004) Patients’ need for information about cancer therapy. Oncology Nursing Forum, 31(2), 313–319. Cross Ref link Pubmed link | Cite this reference
  • 62 Stajduhar, K.I., Neithercut, J., Chu, E., et al. (2000) Thyroid cancer patients’ experience of receiving iodine‐131 therapy. Oncology Nursing Forum, 27(8), 1213–1218. Pubmed link | Cite this reference
  • 63 Stock, R.G., Stone, N., Lo, Y., et al. (2000) Postimplant dosimetry for 125I prostate implants: definitions and factors affecting outcome. International Journal of Radiation, Oncology, Biology, Physics, 48(3), 899–906. Cross Ref link | Cite this reference
  • 64 Syed, A.M., Puthawala, A.A., Abdelaziz, N.N., et al. (2002) Long‐term results of low‐dose‐rate interstitial‐intracavitary brachytherapy in the treatment of carcinoma of the cervix. International Journal of Radiation Oncology, Biology, Physics, 54(1), 67–78. Cross Ref link Pubmed link | Cite this reference
  • 65 Takacsi‐Nagy, Z., Oberna, F., Polgar, C., et al. (2001) The importance of interstitial radiotherapy in the treatment of the base of tongue tumors: a retrospective analysis. Neoplasma, 48(1), 76–81. Pubmed link | Cite this reference
  • 66 Tan, L.T., Russell, S. & Burgess, L. (2004) Acute toxicity of chemo‐radiotherapy for cervical cancer: the Addenbrooke's experience. Clinical Oncology, 16(4), 255–260. Cross Ref link Pubmed link | Cite this reference
  • 67 Teruya, Y., Sakumoto, K., Moromizato, H., et al. (2002) High‐dose intracavitary brachytherapy for carcinoma in situ of the vagina occurring after hysterectomy: a rational prescription of radiation dose. American Journal of Obstetrics and Gynecology, 187(2), 360–364. Cross Ref link Pubmed link | Cite this reference
  • 68 Tessa, M., Rotta, P., Ragona, R., et al. (2005) Concomitant chemotherapy and external radiotherapy plus brachytherapy for locally advanced esophageal cancer: results of a retrospective multicenter study. Tumori, 91(5), 406–414. Cross Ref link Pubmed link | Cite this reference
  • 69 Thompson, M.A. (2001) Radiation safety precautions in the management of the hospitalized 131‐I therapy patient. Nuclear Medicine Technology, 29(2), 61–66. | Cite this reference
  • 70 UK Oral Mucositis in Cancer Group (UKOMiC) (2015) Oral mucositis guidelines. Available at: http://ukomic.co.uk (Accessed: 1/5/2018)
  • 71 Ung, Y.C., Yu, E., Falkson, C., Haynes, A.E., Stys‐Norman, D. & Evans, W.K. (2006) The role of high‐dose‐rate brachytherapy in the palliation of symptoms in patients with non‐small‐cell lung cancer: a systematic review. Brachytherapy, 5(3), 189–202. Cross Ref link Pubmed link | Cite this reference
  • 72 Velji, K. & Fitch, M. (2001) The experience of women receiving brachytherapy for gynecologic cancer. Oncology Nursing Forum, 28(4), 743–751. Pubmed link | Cite this reference
  • 73 Vialard‐Miguel, J., Mazere, J., Mora, S., et al. (2005) [I131 in blood samples: management in the laboratory.] Annales de Biologie Clinique (Paris), 63(5), 561–565. | Cite this reference
  • 74 Wadsley, J.C., Patel, M., Tomlins, C., et al. (2003) Iridium‐192 implantation for T1 and T2a carcinoma of the tongue and floor of mouth: retrospective study of the results of treatment at the Royal Berkshire Hospital. British Journal of Radiology, 76, 414–417. Cross Ref link Pubmed link | Cite this reference
  • 75 Wallace, K., Fleshner, N., Jewett, M., Basiuk, J. & Crook, J. (2006) Impact of a multi‐disciplinary patient education session on accrual to a difficult clinical trial: the Toronto experience with the surgical prostatectomy versus interstitial radiation intervention trial. Journal of Clinical Oncology, 24(25), 4158–4162. Cross Ref link Pubmed link | Cite this reference
  • 76 White, I., Faithfull, S. & Nicholls, P. (2004) UK Survey of Current Practice in Vaginal Dilatation Associated with Pelvic Radiotherapy. European Institute of Health and Medical Sciences (internal document), p. 13. | Cite this reference
  • 77 White, I.D. & Faithfull, S. (2006) Vaginal dilation associated with pelvic radiotherapy: a UK survey of current practice. International Journal of Gynecological Cancer, 16, 1140–1146. Cross Ref link Pubmed link | Cite this reference
  • 78 Williams, C.E. & Woodward, A.F. (2005) Management of the hapless patent after radioiodine ablation therapy. Are we being too strict? Nuclear Medicine Communications, 26(10), 925–928. Cross Ref link Pubmed link | Cite this reference
  • 79 Wong, F.C., Tung, S.Y., Leung, T.W., et al. (2003) Treatment results of high‐dose‐rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens. International Journal of Radiation, Oncology, Biology, Physics, 55(5), 1254–1264. Cross Ref link | Cite this reference
  • 80 Wust, P., von Borczyskowski, D., Henkel, T., et al. (2004) Clinical and physical determinants for toxicity of 125‐I seed brachytherapy. Radiotherapy and Oncology, 73(1), 39–48. Cross Ref link Pubmed link | Cite this reference
  • 81 Zelefsky, M.J. (2006) Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry. Urologic Oncology, 24(4), 377–378. | Cite this reference